Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical tri

Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical tri

Item
http://www.wikidata.org/entity/Q34027424
The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell TransplantationConcurrent treatment with a tumor necrosis factor-alpha inhibitor and veno-venous extracorporeal membrane oxygenation in a post-hematopoietic stem cell transplant patient with idiopathic pneumonia syndrome: a case reportLung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantationTNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521).Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologiesFluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.Advances in T-cell therapy for ALL.Proteome Profiling in Lung Injury after Hematopoietic Stem Cell Transplantation.A call to arms: a critical need for interventions to limit pulmonary toxicity in the stem cell transplantation patient population.Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage.Diagnostic and Prognostic Plasma Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation.Respiratory failure in the hematopoietic stem cell transplant recipient
P2860

Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical tri

Item
http://www.wikidata.org/entity/Q34027424
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Randomized, double-blind, plac ...... marrow transplant clinical tri
@ast
Randomized, double-blind, plac ...... marrow transplant clinical tri
@en
Randomized, double-blind, plac ...... marrow transplant clinical tri
@nl
type
label
Randomized, double-blind, plac ...... marrow transplant clinical tri
@ast
Randomized, double-blind, plac ...... marrow transplant clinical tri
@en
Randomized, double-blind, plac ...... marrow transplant clinical tri
@nl
prefLabel
Randomized, double-blind, plac ...... marrow transplant clinical tri
@ast
Randomized, double-blind, plac ...... marrow transplant clinical tri
@en
Randomized, double-blind, plac ...... marrow transplant clinical tri
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Randomized, double-blind, plac ...... marrow transplant clinical tri
@en
P2093
P2860
P304
P31
P356
10.1016/J.BBMT.2014.02.026
P433
P478
P50
P577
P698
P921
P932